Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.200
-0.160 (-3.67%)
Jul 18, 2025, 4:08 PM HKT
119.90%
Market Cap1.06B
Revenue (ttm)n/a
Net Income (ttm)-93.59M
Shares Out243.42M
EPS (ttm)-0.38
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,180,800
Average Volume1,033,454
Open4.320
Previous Close4.360
Day's Range4.000 - 4.410
52-Week Range1.260 - 5.000
Beta-0.43
RSI66.82
Earnings DateAug 5, 2025

About HKG:2185

Shanghai Bio-heart Biological Technology Co., Ltd. an interventional cardiovascular device company, engages in the research and development of therapies for unmet medical needs of patients in the People’s Republic of China. The company develops Bioheart, a bioresorbable scaffolds (BRS) system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a renal denervation (RDN) product candidate for the treatment of uncontrolled hypertension and resistant hypertension; and drug coated balloon (... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 63
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2185
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.